0 likes | 17 Views
The Vaccine Contract Manufacturing Market is expected to be worth USD 4.1 billion in 2023, rising to USD 9.12 billion by 2033 with a CAGR of 11.7% between 2024 and 2033.<br>This increase in demand reflects growing awareness of vaccination's benefits in poorer countries. This has resulted in the growth of routine immunization programs and the introduction of new vaccines. Companies are beginning to seek contract services for vaccine manufacture as they gain a better knowledge of the complexity and capital requirements of production.<br>
E N D